IPW
IDYA icon

Impact Partnership Wealth’s IDEAYA Biosciences IDYA Stock Holding History

Impact Partnership Wealth’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-76
Closed -$1.79K – 1105
2023
Q2 		$1.79K Buy
+76
New +$1.56K ﹤0.01% 699

Other funds holding IDYA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Impact Partnership Wealth's IDYA Position: Q3 2023 in Review

Impact Partnership Wealth sold out of IDEAYA Biosciences (IDYA) in Q3 2023, closing a stake of 76 shares — an estimated $1.79K sold.

Impact Partnership Wealth first reported a position in IDYA in Q2 2023 and held it in 1 quarter. The position peaked at $1.79K in Q2 2023. 144 funds tracked by Wall St. Rank hold IDYA as of Q3 2023.

  • Impact Partnership Wealth reported no remaining IDEAYA Biosciences position as of Q3 2023 after selling out during the quarter.
  • Impact Partnership Wealth sold 76 IDEAYA Biosciences shares in Q3 2023, an estimated $1.79K.
  • Impact Partnership Wealth first reported a position in IDEAYA Biosciences in Q2 2023 and held it in 1 quarter.
  • Impact Partnership Wealth's IDEAYA Biosciences position peaked at $1.79K in Q2 2023.
  • 144 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2023.

Based on Impact Partnership Wealth's 13F filing for Q3 2023, filed 17 Oct 2023.